Jefferies Initiates Collegium Pharmaceutical At Buy By: Benzinga via Benzinga June 01, 2015 at 08:28 AM EDT Analysts at Jefferies initiated coverage on Collegium Pharmaceutical Inc (NASDAQ: COLL) with a Buy rating. The target price for ... Read More >> Related Stocks: Collegium Pharma